Association of a common polymorphism in the a-subunit gene of factor XIII with myocardial infarction and stroke. Interactions with PAI-1 levels and PAI-1 4G/5G genotype

被引：0
|
作者：
Kohler, HP
Catto, AJ
Stickland, MH
OsseiGerning, N
Carter, A
Mikkola, H
Grant, PJ
机构：
[1] UNIV HELSINKI,DEPT CLIN CHEM,SF-00100 HELSINKI,FINLAND
[2] UNIV LEEDS,RES SCH MED,UNIT MOL VASC MED,LEEDS,W YORKSHIRE,ENGLAND
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：HI15 / HI15
页数：1
相关论文
共 50 条
  • [31] Diabetic microangiopathy and 4G/5G polymorphism of the PAI-1 gene promoter in IDDM
    Pucci, L
    Pilo, M
    Bandinelli, S
    Navalesi, R
    Penno, G
    DIABETES, 1999, 48 : A153 - A153
  • [32] PAI-1 4G/5G Polymorphism and Plasma Levels Association in Patients with Coronary Artery Disease
    Lima, Luciana Moreira
    Carvalho, Maria das Gracas
    Fonseca Neto, Cirilo Pereira
    Faria Garcia, Jose Carlos
    Sousa, Marinez Oliveira
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 97 (06) : 462 - 467
  • [33] PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs
    Balta, G
    Altay, C
    Gurgey, A
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (02) : 89 - 93
  • [34] Association between-675 4G/5G polymorphism of the PAI-1 gene and obesity in men
    Iacoviello, L
    Iacone, R
    Barbato, A
    Volpi, R
    Pampuck, A
    Siani, A
    Farinaro, E
    Pizzorusso, V
    Gerardi, MC
    Strazzullo, P
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S107 - S107
  • [35] Role of the 4G/5G polymorphism of PAI-1 gene promoter on PAI-1 levels in obese patients - Influence of fat distribution and insulin-resistance
    Sartori, MT
    Vettor, R
    De Pergola, G
    De Mitrio, V
    Saggiorato, G
    Della Mea, P
    Patrassi, GM
    Lombardi, AM
    Fabris, R
    Girolami, A
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (05) : 1161 - 1169
  • [36] Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes
    Nagi, DK
    McCormack, LJ
    MohamedAli, V
    Yudkin, JS
    Knowler, WC
    Grant, PJ
    DIABETES CARE, 1997, 20 (08) : 1304 - 1309
  • [37] Relationships between the promoter (4G/5G) polymorphism of the PAI-1 gene, PAI-1 levels, risk factors and complications in Japanese type 2 diabetes
    Ohashi, N
    Takei, I
    Murata, M
    Watanabe, K
    Saruta, T
    DIABETES, 2000, 49 : A93 - A93
  • [38] The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis
    Lorente, Leonardo
    Martin, Maria M.
    Borreguero-Leon, Juan M.
    Barrios, Ysamar
    Sole-Violan, Jordi
    Ferreres, Jose
    Labarta, Lorenzo
    Diaz, Cesar
    Jimenez, Alejandro
    PLOS ONE, 2015, 10 (06):
  • [39] Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
    L Lorente
    M Martín
    L Labarta
    C Díaz
    J Solé-Violán
    J Blanquer
    J Borreguero
    Y Barrios
    Critical Care, 13 (Suppl 1):
  • [40] 4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: A model of gene-environment interaction
    Burzotta, F
    Di Castelnuovo, A
    Amore, C
    D'Orazio, A
    Di Bitondo, R
    Donati, MB
    Iacoviello, L
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (02) : 354 - 358
12345